Advisory committees/consultant: Abbott, Astra-Zeneca, Bayer, Boehringer I, Dexcom, Eli Lilly, GlaxoSmithKline Inc ... Novo Nordisk began marketing the same drug under two different names: Ozempic to ...

Now that the U.S. government has negotiated prices for some Medicare program drugs effective in 2026, Wall Street analysts ...

The British pharma said its shot didn’t meet the efficacy goals of a Phase 2 study. Elsewhere, Zealand reported more obesity ...

Nigeria’s pharmaceutical companies are ramping up investments and expanding operations to tap growing local opportunities.

Originally developed for diabetes, GLP-1 agonists ... Like the other players on this list, GSK does have some weight loss drugs in its pipeline. But the focus among many investors is the company ...

"EC approves GSK’s RSV vaccine for adults aged 50-59 years" was originally created and published by Pharmaceutical Technology ...

This summary of recent health news includes U.S. Senator Bernie Sanders advocating for cheaper Ozempic, new findings on ...

GSK’s depemokimab, a new ultra-long-acting biologic, showed a 54% reduction in severe asthma exacerbations in the SWIFT-1 and ...

Novo Nordisk's older weight-loss drug Saxenda helped children between the ages of 6 and under 12 reduce their body mass index ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...